Immunogenicity Testing of Therapeutic Protein Products —Developing and Validating Assays for Anti-Drug Antibody Detection
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 1, 2019
April 24, 2020
ea78d6b5-b969-4817-b06b-f7e0cfa9b536
Related Documents
Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry
Guidance DocumentDecember 2, 2019Center for Drug Evaluation and Research
Bispecific Antibody Development Programs Guidance for Industry
Guidance DocumentMay 24, 2021Center for Drug Evaluation and Research
Labeling for Human Prescription Drug and Biological Products Approved Under the Accelerated Approval Regulatory Pathway
Guidance DocumentFebruary 4, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox